Development of Technologies for Efficient In Vivo Prime Editing
Description: NARRATIVE Genome editing technologies provide novel opportunities to advance basic research and treat human diseases but approaches that use active nucleases to edit DNA can induce undesired and deleterious effects in the genome, which can reduce their therapeutic potential. Prime editors are a recently emerged gene-editing variant capable of introducing precise modifications to DNA, with minimal damage to the genome. This proposal is focused on creating an integrative prime editing toolkit that will provide investigators with technologies that will enable their use in vivo, improve their specificity and streamline their design and implementation, thereby advancing the applications of this methodology in biotechnology and biomedicine.
Funding type: research
Funder scheme: R01
Start date: 2021-04-01
End date: 2026-02-28
Investigator: PABLO PEREZ-PINERA (lead)
Institutions: University of Illinois Urbana-Champaign, UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
Subfield: Molecular Biology
Domain: Life Sciences
Funded outputs count: 12
Funder award ID: R01GM141296
OpenAlex ID: G7635306544
